U.S. District Judge James Cacheris granted GlaxoSmithKline’s motion for a preliminary injunction blocking the U.S. Patent and Trademark Office from implementing the rules set to go into effect today. Glaxo filed its suit against the U.S. Patent and Trademark Office and its director, Jon Dudas, earlier this month. The company plans to seek a permanent injunction.

Link: Law.com article.